Archive for October 26th, 2011

ALXA AFFY AdCom Meetings. EXEL data. CTIC resubmits NDA + ADLR SGEN ANTH RPTP ANX :

Oct 26, 2011 No Comments by

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced on Monday the FDA has scheduled a meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) for December 12, 2011, at which the ADASUVE New Drug Application (NDA) will be discussed. In August 2011, Alexza received notification that the FDA had accepted the resubmission of the ADASUVE NDA and assigned […]

Daily News Read more